loadpatents
name:-0.02794885635376
name:-0.020331859588623
name:-0.0057449340820312
Barker; Michael David Patent Filings

Barker; Michael David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Barker; Michael David.The latest application filed is for "benzoimidazole derivatives as pad4 inhibitors".

Company Profile
3.18.27
  • Barker; Michael David - Stevenage GB
  • Barker; Michael David - Hertfordshire GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Benzoimidazole derivatives as PAD4 inhibitors
Grant 10,815,218 - Amans , et al. October 27, 2
2020-10-27
Benzoimidazole Derivatives As Pad4 Inhibitors
App 20200095227 - AMANS; Dominique ;   et al.
2020-03-26
Benzoimidazole derivatives as PAD4 inhibitors
Grant 10,407,407 - Amans , et al. Sept
2019-09-10
Benzoimidazole Derivatives As Pad4 Inhibitors
App 20180297983 - Amans; Dominique ;   et al.
2018-10-18
2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors
Grant 10,039,755 - Atkinson , et al. August 7, 2
2018-08-07
2-(azaindol-2-yl) Benzimidazoles As Pad4 Inhibitors
App 20180161316 - Atkinson; Stephen John ;   et al.
2018-06-14
2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors
Grant 9,833,449 - Atkinson , et al. December 5, 2
2017-12-05
Furopyridines as bromodomain inhibitors
Grant 9,670,221 - Amans , et al. June 6, 2
2017-06-06
2- (azaindol-2-yl) Benzimidazoles As Pad4 Inhibitors
App 20170119750 - Atkinson; Stephen John ;   et al.
2017-05-04
2-(azaindol-2-yl) benz imidazoles as PAD4 inhibitors
Grant 9,518,054 - Atkinson , et al. December 13, 2
2016-12-13
Novel Compounds
App 20160355505 - ATKINSON; Francis Louis ;   et al.
2016-12-08
Compounds
Grant 9,447,074 - Atkinson , et al. September 20, 2
2016-09-20
Furopyridines As Bromodomain Inhibitors
App 20160016966 - AMANS; Dominique ;   et al.
2016-01-21
2 - (azaindol-2-yl) Benz Imidazoles As Pad4 Inhibitors
App 20160009716 - Atkinson; Stephen John ;   et al.
2016-01-14
2-(azaindol-2-yl)benzimidazoles as PAD4 inhibitors
Grant 9,127,003 - Atkinson , et al. September 8, 2
2015-09-08
2-(azaindol-2-yl)benzimidazoles As Pad4 Inhibitors
App 20150175600 - Atkinson; Stephen John ;   et al.
2015-06-25
Novel Compounds
App 20150166508 - ATKINSON; Francis Louis ;   et al.
2015-06-18
Compounds
Grant 8,993,560 - Atkinson , et al. March 31, 2
2015-03-31
7-(1H-pyrazol-4-yl)-1,6-naphthyridine compounds as Syk inhibitors
Grant 8,633,319 - Atkinson , et al. January 21, 2
2014-01-21
Pyridinyl- And Pyrazinyl-methyloxy-aryl Derivatives Useful As Inhibitors Of Spleen Tyrosine Kinase (syk)
App 20140005177 - Atkinson; Francis Louis ;   et al.
2014-01-02
Pyrido[3,4-b]pyrazine Derivatives As Syk Inhibitors
App 20140005188 - Atkinson; Francis Louis ;   et al.
2014-01-02
7-(lH-PYRAZOL-4-YL)-1,6-NAPHTHYRIDINE COMPOUNDS AS SYK INHIBITORS
App 20130040984 - Atkinson; Francis Louis ;   et al.
2013-02-14
Novel Compounds
App 20120232061 - Atkinson; Francis Louis ;   et al.
2012-09-13
Purine derivatives as agonists of the adenosine A2A receptor
Grant 7,985,740 - Allen , et al. July 26, 2
2011-07-26
Pyrrolopyridine Compounds, Process For Their Preparation, And Their Use As Medicaments
App 20100179139 - Bamborough; Paul ;   et al.
2010-07-15
Pyrrolo[2,3-b]pyridin-4-yl-benzenesulfonamide Compounds As 1kk2 Inhibitors
App 20100035917 - Bamborough; Paul ;   et al.
2010-02-11
Quinoline Derivatives As Phosphodiesterase Inhibitors
App 20090312325 - Baldwin; Ian Robert ;   et al.
2009-12-17
Quinoline derivatives as phosphodiesterase inhibitors
Grant 7,572,915 - Barker , et al. August 11, 2
2009-08-11
Quinoline derivatives as phosphodiesterase inhibitors
Grant 7,566,786 - Baldwin , et al. July 28, 2
2009-07-28
Purine Derivatives as Agonists of the Adenosine A2a Receptor
App 20080214581 - Allen; David George ;   et al.
2008-09-04
Phenyl-Pyrazole Derivatives as Non-Steroidal Glucocorticoid Receptor Ligands
App 20080207725 - Barker; Michael David ;   et al.
2008-08-28
Novel Compounds
App 20080176891 - Bamborough; Paul ;   et al.
2008-07-24
Novel Compounds
App 20080146606 - Bamborough; Paul ;   et al.
2008-06-19
P38 kinase inhibitors
App 20070161673 - Barker; Michael David ;   et al.
2007-07-12
Quinoline derivatives as phosphodiesterase inhibitors
App 20070142373 - Baldwin; Ian Robert ;   et al.
2007-06-21
Quinoline derivatives as phosphodiesterase inhibitors
App 20060178416 - Barker; Michael David ;   et al.
2006-08-10
2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
Grant 6,528,494 - Cox , et al. March 4, 2
2003-03-04
2-(Purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
Grant 6,426,337 - Cox , et al. July 30, 2
2002-07-30
2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
App 20020086850 - Cox, Brian ;   et al.
2002-07-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed